TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID
Stock Information for TFF Pharmaceuticals Inc - Ordinary Shares
Loading
Please wait while we load your information from QuoteMedia.